Can Fosamax Be Started with Normal Ionized Calcium?
Yes, Fosamax (alendronate) can and should be started when ionized calcium is normal—in fact, normal calcium is a prerequisite for safe initiation. Hypocalcemia must be corrected before starting alendronate, as the drug is absolutely contraindicated in patients with low calcium levels. 1
Pre-Treatment Calcium Requirements
Hypocalcemia is an absolute contraindication to alendronate therapy and must be corrected before initiating treatment. 1 The FDA label explicitly states that "hypocalcemia must be corrected before initiating therapy with FOSAMAX PLUS D." 1
Why This Matters
- Alendronate suppresses bone resorption, which can further decrease serum calcium levels in patients who are already hypocalcemic. 1
- Small, asymptomatic decreases in serum calcium and phosphate may occur during therapy due to alendronate's effects on increasing bone mineral content. 1
- Initiating therapy without correcting hypocalcemia or vitamin D deficiency raises the risk of severe, symptomatic hypocalcemia. 2
Essential Pre-Treatment Steps Before Starting Alendronate
1. Correct Vitamin D Deficiency
- Target serum 25-OH vitamin D level ≥30 ng/mL before starting alendronate. 2, 3
- Vitamin D deficiency should be corrected to prevent bisphosphonate-related hypocalcemia. 2
- Vitamin D repletion can be achieved with ergocalciferol 50,000 IU weekly for 8 weeks before starting alendronate. 2
2. Ensure Adequate Calcium Intake
- Total calcium intake should be approximately 1,200 mg daily from all sources (diet plus supplements). 2, 3
- Vitamin D supplementation of 800–1,000 IU daily is recommended. 2, 3
3. Monitor Calcium During Therapy
- In patients with disorders affecting mineral metabolism (such as vitamin D deficiency), serum calcium and symptoms of hypocalcemia should be monitored during therapy with alendronate. 1
Clinical Algorithm for Starting Alendronate
Step 1: Measure serum ionized calcium (or albumin-corrected total calcium) and 25-OH vitamin D levels.
Step 2: If hypocalcemia is present, do not start alendronate—this is an absolute contraindication. 1
Step 3: If vitamin D is deficient (<30 ng/mL), correct with ergocalciferol 50,000 IU weekly × 8 weeks. 2
Step 4: Once ionized calcium is normal and vitamin D is replete (≥30 ng/mL), alendronate may be safely initiated. 2, 1
Step 5: Ensure the patient can comply with strict administration requirements: take on empty stomach with 6–8 oz plain water, remain upright ≥30 minutes, wait ≥30 minutes before food/beverages/other medications. 2, 1
Common Pitfalls to Avoid
- Starting alendronate in a patient with unrecognized hypocalcemia or vitamin D deficiency can precipitate severe symptomatic hypocalcemia. 2, 1
- Consuming food, coffee, or other beverages with the tablet reduces absorption by up to 60%. 2
- Lying down within 30 minutes of dosing increases the risk of esophageal irritation and ulceration. 2, 1
- Prescribing alendronate to patients with esophageal disorders (stricture, achalasia, dysmotility) or who cannot remain upright markedly increases the risk of serious esophageal complications. 2, 1
Special Considerations
Renal Function
- Calculate creatinine clearance using the Cockcroft-Gault formula with actual body weight. 2
- No dose adjustment is required for creatinine clearance 35–60 mL/min. 2
- Alendronate is contraindicated when creatinine clearance is <35 mL/min. 2
Patients Who Cannot Comply with Oral Administration
If the patient has esophageal disease, cannot stay upright for 30 minutes, has active upper GI disease, or creatinine clearance <35 mL/min, switch to an injectable bisphosphonate (zoledronic acid 5 mg annually) or denosumab 60 mg subcutaneously every 6 months. 3